Wolverine Trading, LLC Viking Therapeutics, Inc. Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

22 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$49.84 - $70.47 $2.49 Million - $3.52 Million	49,900 Added 76.3%	115,300 $7.3 Million
Q2 2024 Aug 14, 2024	SELL	$47.39 - $80.2 $1.02 Million - $1.73 Million	-21,600 Reduced 24.83%	65,400 $3.47 Million
Q1 2024 May 15, 2024	BUY	$17.4 - $94.5 $908,279 - $4.93 Million	52,200 Added 150.0%	87,000 $7.13 Million
Q4 2023 Feb 14, 2024	BUY	$9.24 - $19.64 $145,992 - $310,312	15,800 Added 83.16%	34,800 $647,000
Q3 2023 Nov 15, 2023	SELL	$10.92 - $16.0 $370,188 - $542,400	-33,900 Reduced 64.08%	19,000 $210,000
Q2 2023 Aug 23, 2023	SELL	$14.84 - $24.79 $237,440 - $396,640	-16,000 Reduced 23.22%	52,900 $857,000
Q1 2023 May 15, 2023	BUY	$8.08 - $17.33 $263,408 - $564,958	32,600 Added 89.81%	68,900 $1.19 Million
Q4 2022 Feb 14, 2023	BUY	$2.72 - $9.4 $98,736 - $341,220	36,300 New	36,300 $341,000
Q1 2022 May 16, 2022	SELL	$3.0 - $4.88 $20,100 - $32,696	-6,700 Reduced 34.54%	12,700 $39,000
Q4 2021 Feb 14, 2022	BUY	$4.6 - $6.72 $89,240 - $130,368	19,400 New	19,400 $90,000
Q3 2021 Nov 12, 2021	SELL	$5.58 - $7.04 $97,650 - $123,200	-17,500 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$5.19 - $6.73 $1,557 - $2,019	300 Added 1.74%	17,500 $108,000
Q1 2021 May 14, 2021	BUY	$5.74 - $9.67 $98,728 - $166,324	17,200 New	17,200 $104,000
Q4 2020 Feb 12, 2021	SELL	$5.3 - $6.71 $120,310 - $152,317	-22,700 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$5.73 - $8.11 $1,146 - $1,622	-200 Reduced 0.87%	22,700 $135,000
Q2 2020 Aug 13, 2020	SELL	$4.35 - $8.08 $38,280 - $71,104	-8,800 Reduced 27.76%	22,900 $166,000
Q1 2020 May 11, 2020	BUY	$3.45 - $7.95 $109,365 - $252,015	31,700 New	31,700 $150,000
Q4 2019 Feb 12, 2020	SELL	$6.38 - $8.73 $246,268 - $336,978	-38,600 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$6.55 - $8.6 $252,830 - $331,960	38,600 New	38,600 $268,000
Q1 2019 May 15, 2019	SELL	$7.58 - $9.94 $674,620 - $884,660	-89,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$7.16 - $16.21 $276,376 - $625,706	-38,600 Reduced 30.25%	89,000 $674,000
Q3 2018 Nov 14, 2018	BUY	$9.7 - $19.65 $1.24 Million - $2.51 Million	127,600 New	127,600 $2.22 Million

Others Institutions Holding VKTX

# of Institutions

473

Shares Held

65.6M

Call Options Held

5.72M

Put Options Held

3.39M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $3.25B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account